IL17A and systemic lupus erythematosus: To evaluate the differentiation of each effector CD4+T-cell subset, splenic CD4+IFN-γ+, CD4+IL-17a+, and CD4+CD25+FOXP3+ Tregs by anti-CD3 treatment in the late phase of lupus was stained and detected by flow cytometry.